Structure

Physi-Chem Properties

Molecular Weight:  912.74
Volume:  1037.738
LogP:  17.565
LogD:  5.793
LogS:  -6.861
# Rotatable Bonds:  51
TPSA:  108.36
# H-Bond Aceptor:  8
# H-Bond Donor:  1
# Rings:  1
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.03
Synthetic Accessibility Score:  3.234
Fsp3:  0.807
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.46
MDCK Permeability:  4.849059109801601e-07
Pgp-inhibitor:  0.0
Pgp-substrate:  0.59
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  1.0
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.0
Plasma Protein Binding (PPB):  110.79996490478516%
Volume Distribution (VD):  5.388
Pgp-substrate:  0.17395800352096558%

ADMET: Metabolism

CYP1A2-inhibitor:  0.005
CYP1A2-substrate:  0.093
CYP2C19-inhibitor:  0.065
CYP2C19-substrate:  0.03
CYP2C9-inhibitor:  0.004
CYP2C9-substrate:  0.995
CYP2D6-inhibitor:  0.032
CYP2D6-substrate:  0.004
CYP3A4-inhibitor:  0.087
CYP3A4-substrate:  0.011

ADMET: Excretion

Clearance (CL):  4.373
Half-life (T1/2):  0.022

ADMET: Toxicity

hERG Blockers:  0.605
Human Hepatotoxicity (H-HT):  0.01
Drug-inuced Liver Injury (DILI):  0.282
AMES Toxicity:  0.011
Rat Oral Acute Toxicity:  0.004
Maximum Recommended Daily Dose:  0.036
Skin Sensitization:  0.996
Carcinogencity:  0.02
Eye Corrosion:  0.006
Eye Irritation:  0.795
Respiratory Toxicity:  0.197

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475468

Natural Product ID:  NPC475468
Common Name*:   1,3-Dibehenyl-2-Ferulyl Glyceride
IUPAC Name:   [3-docosanoyloxy-2-[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxypropyl] docosanoate
Synonyms:   NSC-332563
Standard InCHIKey:  HQKOKDBCUSEPCE-LIIAXHHNSA-N
Standard InCHI:  InChI=1S/C57H100O8/c1-4-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-42-55(59)63-49-52(65-57(61)47-45-51-44-46-53(58)54(48-51)62-3)50-64-56(60)43-41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-5-2/h44-48,52,58H,4-43,49-50H2,1-3H3/b47-45+
SMILES:  CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)OC(=O)C=CC1=CC(=C(C=C1)O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL506193
PubChem CID:   5988101
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000175] Glycerolipids
        • [CHEMONTID:0003815] Triradylcglycerols
          • [CHEMONTID:0001135] Triacylglycerols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1692 Aquilaria malaccensis Species Thymelaeaceae Eukaryota Seeds n.a. n.a. PMID[28445049]
NPO1692 Aquilaria malaccensis Species Thymelaeaceae Eukaryota Agarwood n.a. n.a. PMID[29083898]
NPO1692 Aquilaria malaccensis Species Thymelaeaceae Eukaryota n.a. n.a. n.a. PMID[30672698]
NPO1692 Aquilaria malaccensis Species Thymelaeaceae Eukaryota n.a. n.a. n.a. PMID[7320738]
NPO1692 Aquilaria malaccensis Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus ED50 = 0.8 ug ml-1 PMID[538223]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475468 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9766 High Similarity NPC471110
0.9365 High Similarity NPC280767
0.9286 High Similarity NPC60517
0.9286 High Similarity NPC20443
0.9286 High Similarity NPC146886
0.9225 High Similarity NPC83062
0.9134 High Similarity NPC312404
0.9134 High Similarity NPC273686
0.9111 High Similarity NPC289690
0.9111 High Similarity NPC288452
0.9055 High Similarity NPC164778
0.9055 High Similarity NPC257976
0.9055 High Similarity NPC242372
0.9055 High Similarity NPC4181
0.9048 High Similarity NPC177291
0.9048 High Similarity NPC194416
0.903 High Similarity NPC90431
0.8992 High Similarity NPC120225
0.8992 High Similarity NPC213552
0.8976 High Similarity NPC114298
0.8968 High Similarity NPC204466
0.8931 High Similarity NPC241354
0.8923 High Similarity NPC123228
0.8923 High Similarity NPC123722
0.8923 High Similarity NPC276466
0.8923 High Similarity NPC5018
0.8923 High Similarity NPC151167
0.8921 High Similarity NPC53884
0.8921 High Similarity NPC258671
0.8915 High Similarity NPC289459
0.8898 High Similarity NPC70752
0.8897 High Similarity NPC284409
0.8889 High Similarity NPC202474
0.8881 High Similarity NPC135127
0.8855 High Similarity NPC278308
0.8849 High Similarity NPC304956
0.8849 High Similarity NPC469615
0.8846 High Similarity NPC179777
0.8846 High Similarity NPC84076
0.8846 High Similarity NPC90128
0.8846 High Similarity NPC303680
0.8837 High Similarity NPC246704
0.8819 High Similarity NPC158949
0.8815 High Similarity NPC113295
0.8794 High Similarity NPC299090
0.8794 High Similarity NPC143892
0.8794 High Similarity NPC221383
0.8794 High Similarity NPC283081
0.8788 High Similarity NPC304622
0.8786 High Similarity NPC469683
0.8779 High Similarity NPC12022
0.8779 High Similarity NPC20404
0.8779 High Similarity NPC20287
0.8779 High Similarity NPC293641
0.876 High Similarity NPC163083
0.875 High Similarity NPC201777
0.8741 High Similarity NPC300776
0.8741 High Similarity NPC68779
0.8741 High Similarity NPC106406
0.8741 High Similarity NPC176814
0.8741 High Similarity NPC4982
0.8741 High Similarity NPC5310
0.8732 High Similarity NPC472969
0.873 High Similarity NPC107588
0.873 High Similarity NPC309434
0.873 High Similarity NPC164706
0.873 High Similarity NPC137537
0.873 High Similarity NPC272471
0.873 High Similarity NPC203124
0.873 High Similarity NPC205502
0.873 High Similarity NPC70744
0.8723 High Similarity NPC98356
0.8722 High Similarity NPC172673
0.8714 High Similarity NPC160378
0.8676 High Similarity NPC470990
0.8671 High Similarity NPC478242
0.8667 High Similarity NPC168799
0.8667 High Similarity NPC155209
0.8661 High Similarity NPC299406
0.8636 High Similarity NPC281020
0.8633 High Similarity NPC100675
0.863 High Similarity NPC469888
0.8626 High Similarity NPC257589
0.8626 High Similarity NPC53305
0.8621 High Similarity NPC473773
0.8621 High Similarity NPC475579
0.8613 High Similarity NPC120852
0.8601 High Similarity NPC98009
0.8594 High Similarity NPC2058
0.8593 High Similarity NPC239302
0.8593 High Similarity NPC61
0.8593 High Similarity NPC25581
0.8593 High Similarity NPC5419
0.8593 High Similarity NPC111888
0.8593 High Similarity NPC18074
0.8582 High Similarity NPC319282
0.8582 High Similarity NPC123196
0.8582 High Similarity NPC244246
0.8582 High Similarity NPC215941
0.8582 High Similarity NPC137427
0.8582 High Similarity NPC311419
0.8582 High Similarity NPC275724
0.8582 High Similarity NPC65935
0.8571 High Similarity NPC226661
0.8571 High Similarity NPC109275
0.8571 High Similarity NPC110313
0.8571 High Similarity NPC281277
0.8571 High Similarity NPC131532
0.8561 High Similarity NPC106055
0.8561 High Similarity NPC127937
0.8561 High Similarity NPC147379
0.8561 High Similarity NPC276014
0.8561 High Similarity NPC110699
0.8561 High Similarity NPC92207
0.8552 High Similarity NPC118033
0.8552 High Similarity NPC243891
0.8552 High Similarity NPC300329
0.8551 High Similarity NPC126206
0.8551 High Similarity NPC281780
0.8542 High Similarity NPC476394
0.8542 High Similarity NPC98809
0.8538 High Similarity NPC286573
0.8529 High Similarity NPC159418
0.8529 High Similarity NPC129889
0.8529 High Similarity NPC307006
0.8529 High Similarity NPC327410
0.8529 High Similarity NPC283823
0.8527 High Similarity NPC470848
0.8527 High Similarity NPC470849
0.8521 High Similarity NPC274960
0.8521 High Similarity NPC143120
0.8521 High Similarity NPC473909
0.8519 High Similarity NPC198388
0.8519 High Similarity NPC469480
0.8516 High Similarity NPC24474
0.8516 High Similarity NPC311595
0.8516 High Similarity NPC37858
0.8514 High Similarity NPC473275
0.8514 High Similarity NPC470896
0.8507 High Similarity NPC48315
0.8496 Intermediate Similarity NPC16651
0.8496 Intermediate Similarity NPC32163
0.8493 Intermediate Similarity NPC246566
0.8493 Intermediate Similarity NPC267091
0.8493 Intermediate Similarity NPC476434
0.8493 Intermediate Similarity NPC95498
0.8493 Intermediate Similarity NPC75695
0.8492 Intermediate Similarity NPC233669
0.8483 Intermediate Similarity NPC221091
0.8483 Intermediate Similarity NPC259576
0.8478 Intermediate Similarity NPC471665
0.8478 Intermediate Similarity NPC157554
0.8478 Intermediate Similarity NPC471664
0.8473 Intermediate Similarity NPC106659
0.8473 Intermediate Similarity NPC21238
0.8473 Intermediate Similarity NPC244876
0.8473 Intermediate Similarity NPC229084
0.8473 Intermediate Similarity NPC160900
0.8473 Intermediate Similarity NPC18984
0.8472 Intermediate Similarity NPC1580
0.8456 Intermediate Similarity NPC50763
0.8451 Intermediate Similarity NPC473090
0.8444 Intermediate Similarity NPC142985
0.8444 Intermediate Similarity NPC66905
0.8444 Intermediate Similarity NPC195292
0.844 Intermediate Similarity NPC472410
0.844 Intermediate Similarity NPC253481
0.844 Intermediate Similarity NPC31751
0.844 Intermediate Similarity NPC253722
0.844 Intermediate Similarity NPC52664
0.844 Intermediate Similarity NPC67467
0.844 Intermediate Similarity NPC140502
0.8435 Intermediate Similarity NPC105942
0.8435 Intermediate Similarity NPC44730
0.8435 Intermediate Similarity NPC205392
0.8435 Intermediate Similarity NPC146277
0.8435 Intermediate Similarity NPC19380
0.8433 Intermediate Similarity NPC478215
0.8429 Intermediate Similarity NPC474784
0.8429 Intermediate Similarity NPC322021
0.8425 Intermediate Similarity NPC475454
0.8425 Intermediate Similarity NPC475311
0.8425 Intermediate Similarity NPC473680
0.8425 Intermediate Similarity NPC473579
0.8417 Intermediate Similarity NPC67349
0.8417 Intermediate Similarity NPC279676
0.8413 Intermediate Similarity NPC328593
0.8413 Intermediate Similarity NPC33749
0.8413 Intermediate Similarity NPC294941
0.8413 Intermediate Similarity NPC261453
0.8409 Intermediate Similarity NPC288945
0.8406 Intermediate Similarity NPC204592
0.8406 Intermediate Similarity NPC477301
0.8394 Intermediate Similarity NPC200422
0.8394 Intermediate Similarity NPC289572
0.8394 Intermediate Similarity NPC295406
0.8394 Intermediate Similarity NPC157478
0.8392 Intermediate Similarity NPC100998
0.8392 Intermediate Similarity NPC34927
0.8392 Intermediate Similarity NPC252292

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475468 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8473 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.8358 Intermediate Similarity NPD9494 Approved
0.8175 Intermediate Similarity NPD228 Approved
0.8056 Intermediate Similarity NPD8166 Discontinued
0.8 Intermediate Similarity NPD230 Phase 1
0.8 Intermediate Similarity NPD447 Suspended
0.8 Intermediate Similarity NPD6190 Approved
0.7972 Intermediate Similarity NPD7266 Discontinued
0.7939 Intermediate Similarity NPD5536 Phase 2
0.7931 Intermediate Similarity NPD4110 Phase 3
0.7931 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7908 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7891 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7872 Intermediate Similarity NPD6355 Discontinued
0.7857 Intermediate Similarity NPD1358 Approved
0.7857 Intermediate Similarity NPD6233 Phase 2
0.7842 Intermediate Similarity NPD3027 Phase 3
0.7817 Intermediate Similarity NPD6653 Approved
0.7808 Intermediate Similarity NPD4628 Phase 3
0.7786 Intermediate Similarity NPD6798 Discontinued
0.7778 Intermediate Similarity NPD2935 Discontinued
0.7748 Intermediate Similarity NPD3455 Phase 2
0.773 Intermediate Similarity NPD4062 Phase 3
0.7716 Intermediate Similarity NPD7685 Pre-registration
0.7712 Intermediate Similarity NPD1934 Approved
0.7707 Intermediate Similarity NPD8127 Discontinued
0.7692 Intermediate Similarity NPD7843 Approved
0.7692 Intermediate Similarity NPD6234 Discontinued
0.7682 Intermediate Similarity NPD1653 Approved
0.7677 Intermediate Similarity NPD3882 Suspended
0.7638 Intermediate Similarity NPD3134 Approved
0.7636 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD3817 Phase 2
0.7612 Intermediate Similarity NPD9545 Approved
0.7589 Intermediate Similarity NPD7095 Approved
0.7574 Intermediate Similarity NPD3496 Discontinued
0.7556 Intermediate Similarity NPD1357 Approved
0.7552 Intermediate Similarity NPD4060 Phase 1
0.7552 Intermediate Similarity NPD825 Approved
0.7552 Intermediate Similarity NPD826 Approved
0.7548 Intermediate Similarity NPD2801 Approved
0.7548 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7535 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7534 Intermediate Similarity NPD2438 Suspended
0.7531 Intermediate Similarity NPD7054 Approved
0.7519 Intermediate Similarity NPD7157 Approved
0.7518 Intermediate Similarity NPD6832 Phase 2
0.7516 Intermediate Similarity NPD7075 Discontinued
0.75 Intermediate Similarity NPD1241 Discontinued
0.75 Intermediate Similarity NPD5283 Phase 1
0.75 Intermediate Similarity NPD4626 Approved
0.75 Intermediate Similarity NPD5647 Approved
0.75 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7074 Phase 3
0.7485 Intermediate Similarity NPD7472 Approved
0.7484 Intermediate Similarity NPD37 Approved
0.7481 Intermediate Similarity NPD1894 Discontinued
0.7469 Intermediate Similarity NPD7228 Approved
0.7469 Intermediate Similarity NPD3818 Discontinued
0.7464 Intermediate Similarity NPD9717 Approved
0.7453 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD6166 Phase 2
0.7453 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD4966 Approved
0.7452 Intermediate Similarity NPD4965 Approved
0.7452 Intermediate Similarity NPD4967 Phase 2
0.7439 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD2797 Approved
0.7426 Intermediate Similarity NPD5691 Approved
0.7419 Intermediate Similarity NPD6385 Approved
0.7419 Intermediate Similarity NPD6386 Approved
0.7396 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD1535 Discovery
0.7385 Intermediate Similarity NPD2684 Approved
0.7379 Intermediate Similarity NPD1933 Approved
0.7379 Intermediate Similarity NPD555 Phase 2
0.7372 Intermediate Similarity NPD1778 Approved
0.7357 Intermediate Similarity NPD1283 Approved
0.7349 Intermediate Similarity NPD7808 Phase 3
0.7349 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD1481 Phase 2
0.7338 Intermediate Similarity NPD9269 Phase 2
0.7333 Intermediate Similarity NPD9493 Approved
0.7333 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD6232 Discontinued
0.7325 Intermediate Similarity NPD7819 Suspended
0.7325 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD1006 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD1465 Phase 2
0.7319 Intermediate Similarity NPD3847 Discontinued
0.7317 Intermediate Similarity NPD5844 Phase 1
0.7315 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD4534 Discontinued
0.731 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD1613 Approved
0.731 Intermediate Similarity NPD3620 Phase 2
0.7305 Intermediate Similarity NPD1203 Approved
0.7303 Intermediate Similarity NPD6799 Approved
0.7303 Intermediate Similarity NPD1511 Approved
0.7301 Intermediate Similarity NPD7473 Discontinued
0.7297 Intermediate Similarity NPD2239 Approved
0.7297 Intermediate Similarity NPD2240 Approved
0.7292 Intermediate Similarity NPD3268 Approved
0.7292 Intermediate Similarity NPD411 Approved
0.7289 Intermediate Similarity NPD7251 Discontinued
0.7279 Intermediate Similarity NPD7097 Phase 1
0.7278 Intermediate Similarity NPD5353 Approved
0.7267 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD7199 Phase 2
0.7266 Intermediate Similarity NPD3705 Approved
0.7255 Intermediate Similarity NPD3146 Approved
0.7255 Intermediate Similarity NPD3688 Clinical (unspecified phase)
0.7254 Intermediate Similarity NPD258 Approved
0.7254 Intermediate Similarity NPD257 Approved
0.7244 Intermediate Similarity NPD4380 Phase 2
0.7241 Intermediate Similarity NPD2674 Phase 3
0.7241 Intermediate Similarity NPD259 Phase 1
0.723 Intermediate Similarity NPD2799 Discontinued
0.7229 Intermediate Similarity NPD6797 Phase 2
0.7226 Intermediate Similarity NPD3686 Approved
0.7226 Intermediate Similarity NPD3687 Approved
0.7214 Intermediate Similarity NPD1608 Approved
0.7208 Intermediate Similarity NPD1512 Approved
0.7208 Intermediate Similarity NPD6273 Approved
0.72 Intermediate Similarity NPD5958 Discontinued
0.7197 Intermediate Similarity NPD3021 Approved
0.7197 Intermediate Similarity NPD3022 Approved
0.7197 Intermediate Similarity NPD6873 Phase 2
0.7192 Intermediate Similarity NPD2979 Phase 3
0.7183 Intermediate Similarity NPD6362 Approved
0.7179 Intermediate Similarity NPD7458 Discontinued
0.7179 Intermediate Similarity NPD824 Approved
0.7178 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD290 Approved
0.7174 Intermediate Similarity NPD5585 Approved
0.717 Intermediate Similarity NPD5402 Approved
0.7161 Intermediate Similarity NPD5403 Approved
0.7153 Intermediate Similarity NPD2614 Approved
0.7153 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6801 Discontinued
0.7143 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD422 Phase 1
0.7143 Intermediate Similarity NPD1281 Approved
0.7134 Intermediate Similarity NPD7028 Phase 2
0.7125 Intermediate Similarity NPD7768 Phase 2
0.7124 Intermediate Similarity NPD7440 Discontinued
0.7123 Intermediate Similarity NPD8032 Phase 2
0.7123 Intermediate Similarity NPD1726 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD6663 Approved
0.7114 Intermediate Similarity NPD4308 Phase 3
0.7107 Intermediate Similarity NPD8455 Phase 2
0.7105 Intermediate Similarity NPD3750 Approved
0.7105 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD2653 Approved
0.7086 Intermediate Similarity NPD2424 Discontinued
0.7083 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD7038 Approved
0.7083 Intermediate Similarity NPD9569 Approved
0.7083 Intermediate Similarity NPD5736 Approved
0.7083 Intermediate Similarity NPD7039 Approved
0.7081 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD4357 Discontinued
0.707 Intermediate Similarity NPD3111 Phase 1
0.707 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD9570 Approved
0.7067 Intermediate Similarity NPD6032 Approved
0.7067 Intermediate Similarity NPD1501 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD1551 Phase 2
0.7059 Intermediate Similarity NPD2354 Approved
0.7059 Intermediate Similarity NPD3887 Approved
0.7059 Intermediate Similarity NPD690 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD2821 Approved
0.7055 Intermediate Similarity NPD3145 Approved
0.7055 Intermediate Similarity NPD3764 Approved
0.7055 Intermediate Similarity NPD3144 Approved
0.7054 Intermediate Similarity NPD291 Approved
0.705 Intermediate Similarity NPD9268 Approved
0.705 Intermediate Similarity NPD1651 Approved
0.7042 Intermediate Similarity NPD2983 Phase 2
0.7042 Intermediate Similarity NPD2982 Phase 2
0.7037 Intermediate Similarity NPD5535 Approved
0.7032 Intermediate Similarity NPD2533 Approved
0.7032 Intermediate Similarity NPD5401 Approved
0.7032 Intermediate Similarity NPD2532 Approved
0.7032 Intermediate Similarity NPD2534 Approved
0.7027 Intermediate Similarity NPD4340 Discontinued
0.7025 Intermediate Similarity NPD6599 Discontinued
0.702 Intermediate Similarity NPD5762 Approved
0.702 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD6005 Phase 3
0.702 Intermediate Similarity NPD6002 Phase 3
0.702 Intermediate Similarity NPD6004 Phase 3
0.702 Intermediate Similarity NPD5763 Approved
0.7014 Intermediate Similarity NPD1019 Discontinued
0.7007 Intermediate Similarity NPD6671 Approved
0.7 Intermediate Similarity NPD1510 Phase 2
0.7 Intermediate Similarity NPD7033 Discontinued
0.7 Intermediate Similarity NPD17 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data